Prescient Therapeutics LimitedASX: PTX

Phase 1b/2 Ovarian Trial Commences 2nd Dose Escalation

Dec 8, 2016 at 7:17 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment